Associate Key Account Director

• Jan 2023 - Present

Marketing Lead BeLux at Galapagos a.i.

• Sep 2021 - Sep 2022

Business Unit Director: Respiratory

• Jan 2015 - Sep 2021

In my current role, I oversee commercialisation of prescription medications that treat respiratory diseases, by leading science-based business transformation and innovation plans, spearheading tailored strategies to generate growth, increase profitability, and improve patients' lives. I elevate Novartis Pharma's brand through directing the execution of impactful marketing campaigns across multiple digital platforms. As a leader, I supervise, train, and motivate Marketing & Sales Managers towards exceeding targets and enhancing productivity levels. Finally, I streamline finances by controlling budgets, devising cost-effective plans, and allocating resources.Achievements include:• Successfully designed and implemented Novartis KOL programme.• Pre-marketed and launched Enerzair and Atectura Breezhaler (2021) for treating asthma. Show less

Head of Sales: Primary Care BeLux (Cardiology, Diabetes, Osteoporosis, Respiratory)

• Jan 2012 - Jan 2015

I was responsible for heading Sales departmental activities through actively tracking staff performance, monitoring the development of business products from conceptualisation through to testing and launch, as well as defining and communicated business KPIs and objectives to junior sales personnel. Furthermore, I analysed patterns in consumer, market behaviour, and competitor operations, while outlining data-driven action strategies that optimised commercial performance. I structured budgets and efficiently tracked expenses with the purpose of delivering ROI.Achievements include:• Observed brand, delivered accurate forecasts, and identified new trends, which offered business competitive advantage over competition in market.• Enabled sales improvements and product mix development, while managing launches, promotions, exclusive contracts, and campaign processes.• Partnered with Product Development team in creating product/brand adjacencies that boosted market share.• Remained updated on latest pharmaceutical trends, further sustaining business as one of the top industry players. Show less

Head of Marketing: Primary Care BeLux (Cardiology, Diabetes, Osteoporosis, Respiratory)

• Jan 2011 - Dec 2011

I partnered with business teams in uncovering insights to implement marketing and branding strategies for new/existing products. In additional, I understood key marketing performance metrics and tracking tools to provide market research, forecasts, competitive analysis, and campaign results. I secured new accounts through recognising revenue opportunities and facilitating consistent growth. Lastly, I established budget and resource needs, including management profit & loss projections, expenditure spending, and other financial considerations.Achievements include:• Relaunched Galvus/Eucreas medication for treating diabetes, as well as delivered growth with Exforge (blood pressure drug) and Aclasta (bone disease treatment drug).• Pre-marketed and launched Onbrez Breezhaler, Seebri Breezhaler, and Ultibro Breezhaler, which are regarded as world leading drugs in treating chronic obstructive pulmonary disease – COPD.• Provided ongoing training which ensured teams continuously performed above expectation.• Revamped marketing operations in cooperation with creative & content teams and distribution partners, which ensured products and services reached wider customer base. Show less

Marketing & Sales Manager: Respiratory BeLux (Asthma, Cystic Fibrosis)

• Jan 2010 - Dec 2010

I was tasked with promoted the organisation’s brand and introduced new products to market, as well as analysing budget plans, scheduled expenditure, ensured that teams attained sales quotas. I studied and developed marketing opportunities to interpret consumer requirements and determine system advancements. Finally, I Produced detailed reports concerning gathered and summarised market data and trends.Achievements include:• Launched industry-renowned asthma Omalizumab programme.• Launched Tobi – antibiotic which treats cystic fibrosis.• Capitalised on opportunities which supported market penetration efforts across numerous regions. Show less